Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of Thoracic Surgery

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ATHORACSUR.2006.10.046PMID 17307447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease

  2006cited by this paper
• Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis

  2005cited by this paper
• Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator.

  2005cited by this paper
• Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.

  2005cited by this paper
• Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.

  2005cited by this paper
• Clinical trials update from the European Society of Cardiology meeting 2005: CARE‐HF extension study, ESSENTIAL, CIBIS‐III, S‐ICD, ISSUE‐2, STRIDE‐2, SOFA, IMAGINE, PREAMI, SIRIUS‐II and ACTIVE

  2005cited by this paper
• The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.

  2005cited by this paper
• Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

  2004cited by this paper
• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

  2004cited by this paper
• Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes

  2004cited by this paper
• Secondary prevention after coronary artery bypass graft: a primary issue?

  2004cited by this paper
• ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

  2004cited by this paper
• Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.

  2004cited by this paper
• Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

  2003cited by this paper
• Effect of preoperative β‐blockade on perioperative mortality in coronary surgery

  2003cited by this paper
• Effect of preoperative beta-blockade on perioperative mortality in coronary surgery.

  2003cited by this paper
• Patterns of Secondary Prevention in Older Patients Undergoing Coronary Artery Bypass Grafting During Hospitalization for Acute Myocardial Infarction

  2003cited by this paper
• Preoperative β-blocker use and mortality and morbidity following CABG surgery in North America ☆

  2002cited by this paper
• ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary

  2002cited by this paper
• Mortality and recurrent cardiac events after coronary artery bypass graft: long term outcomes in a population study

  2002cited by this paper
• Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale.

  2002cited by this paper
• A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons.

  2002cited by this paper
• Aspirin and mortality from coronary bypass surgery.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America.

  2002cited by this paper
• Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.

  2001cited by this paper
• Effect of carvedilol on survival in severe chronic heart failure.

  2001cited by this paper
• Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab

  2000cited by this paper
• The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES).

  2000cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

  2000cited by this paper
• Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial

  2000cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients

  2000cited by this paper
• Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?

  2000cited by this paper
• Are β-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?

  2000cited by this paper
• Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• ACC/AHA guidelines for coronary artery bypass graft surgery

  1999cited by this paper
• The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

  1997cited by this paper
• Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.

  1995cited by this paper
• The MACB Study Group. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Aspirin use and survival after coronary bypass surgery.

  1992cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.

  1982cited by this paper
• Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

  1981cited by this paper
• ORIGINAL CONTRIBUTION Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes

  year unknowncited by this paper

• Trends in prescribing optimal medical therapy at discharge following percutaneous coronary intervention in a tertiary care hospital in the UAE

  2025cites this paper
• Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery.

  2024cites this paper
• Sex Differences in Long-Term Outcomes in Patients With Chronic Coronary Syndrome After Percutaneous Coronary Intervention　- Insights From a Japanese Real-World Database Using a Storage System.

  2023cites this paper
• A retrospective study on adherence to secondary prevention medications after coronary bypass surgery.

  2022cites this paper
• Adherence to Prescribing Guideline-Directed Medical Therapy at Hospital Discharge in Subjects With Acute Coronary Syndrome, and the Relationship With Mortality

  2022cites this paper
• Attainment of Lipid Targets Following Coronary Artery Bypass Graft Surgery: Can We Do Better?

  2022cites this paper
• Beta blockers and long-term outcome after coronary artery bypass grafting: a nationwide observational study

  2022cites this paper
• Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trial.

  2022cites this paper
• Impact of renin-angiotensin system inhibitors after revascularization of patients with left main coronary artery disease

  2021cites this paper
• Statins for secondary prevention and major adverse events after coronary artery bypass grafting.

  2021cites this paper
• Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.

  2021cites this paper
• Effect of a Smartphone-Based Intervention on Secondary Prevention Medication Prescriptions After Coronary Artery Bypass Graft Surgery: The MISSION-1 Randomized Controlled Trial.

  2021cites this paper
• Secondary Prevention Medications Post Coronary Artery Bypass Grafting Surgery—A Literature Review

  2021cites this paper
• Optimizing medical therapy in the coronary artery bypass graft patient

  2021cites this paper
• Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease

  2021cites this paper
• The Independent Reduction in Mortality Associated with Guideline-Directed Medical Therapy in Patients with Coronary Artery Disease and Heart Failure with Reduced Ejection Fraction.

  2020cites this paper
• Association between β-Blocker and Outcome of Coronary Artery Bypass Graft: Before and After 1 Year.

  2020cites this paper
• Efficacy of a WeChat-based intervention for adherence to secondary prevention therapies in patients undergoing coronary artery bypass graft in China: A randomized controlled trial

  2020influential citation
• Smartphone-based application to improve medication adherence in patients after surgical coronary revascularization.

  2020cites this paper
• Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker Based Optimal Medical Therapy after Percutaneous Coronary Intervention: A Nationwide Cohort Study.

  2020cites this paper
• Impact of Modifiable Risk Factors on Long-Term Outcomes after Coronary Artery Bypass Surgery

  2020cites this paper
• Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization

  2019cites this paper
• Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry

  2019cites this paper
• Clopidogrel Adherence to AHA/ACC Guideline in Patients with Open Heart Surgery in a Tertiary Heart Center

  2019influential citation
• The surgeon's role in optimizing medical therapy and maintaining compliance with secondary prevention guidelines in patients undergoing coronary artery bypass grafting.

  2019cites this paper
• Trends, Characteristics, and Clinical Outcomes of Patients Undergoing Percutaneous Coronary Intervention in Korea between 2011 and 2015

  2018cites this paper
• Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study

  2018cites this paper
• Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence (MISSION-2)

  2018cites this paper
• Ключевые недостатки вторичной профилактики ишемической болезни сердца с помощью лекарственной терапии: роль комбинированных препаратов с постоянными дозами в решении проблемы

  2018cites this paper
• Key Drawbacks of Secondary Ischemic Heart Disease Prevention With Drug Therapy: the Role of Combination Fixed Dose Preparations in Solution of This Problem

  2018cites this paper
• Pharmacotherapy Evaluation and Utilization in Coronary Artery Bypass Grafting Patients in Kosovo during the Period 2016-2017

  2018influential citation
• The short‐ and long‐term outcomes of percutaneous intervention with drug‐eluting stent vs bare‐metal stent in saphenous vein graft disease: An updated meta‐analysis of all randomized clinical trials

  2018cites this paper
• Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials.

  2018cites this paper
• Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?

  2017cites this paper
• Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome.

  2017cites this paper
• Invited commentaryInvited Commentary

  2017cites this paper
• Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia

  2016influential citation
• Rationale and Design of a Randomized Cluster Trial to Improve Guideline-Adherence of Secondary Preventive Drugs Prescription after Coronary Artery Bypass Grafting in China: MISSION-1 Study

  2016cites this paper
• Efficacy of &bgr;-blocker therapy for secondary prevention for patients undergoing coronary artery bypass grafting surgery

  2016cites this paper
• Specific needs, concerns, strategies and advice of caregivers after coronary artery bypass surgery.

  2016cites this paper
• Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate

  2016cites this paper
• Arterial Graft Failure

  2016cites this paper
• Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.

  2016cites this paper
• Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association.

  2015influential citation
• Secondary Prevention After Coronary Artery Bypass Graft Surgery A Scientific Statement From the American Heart Association

  2015influential citation
• Medication Adherence After CABG and its Related to Medication Belief

  2015cites this paper
• Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery

  2015cites this paper
• VEIN GRAFT PATENCY IN POST-CABG SYMPTOMATIC PATIENTS : AN ANGIOGRAPHIC STUDY

  2015cites this paper
• Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Fol

  2015cites this paper
• Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization with Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the SYNTAX Trial at 5-Year Follow-Up

  2015cites this paper
• ’ Neal , Wesley T . , Jimmy T . Efird , Stephen

  2014cites this paper
• SAC 2012 Consensus Statement on Cardiovascular Recovery

  2014cites this paper
• A pre-printed medication chart in the ICU for patients admitted af- ter coronary artery bypass graft surgery improves prescribing of secondary prevention at hospital discharge

  2014cites this paper
• Discharge β-Blocker Use and Race after Coronary Artery Bypass Grafting

  2014cites this paper
• Evaluation of Preventive Cardiovascular Pharmacotherapy after Coronary Artery Bypass Graft Surgery

  2014influential citation
• Coronary artery bypass grafting: Part 2--optimizing outcomes and future prospects.

  2013cites this paper
• Short- and Long-term Impact of an Inpatient Quality Improvement Initiative: RESULTS OF THE CABG-GAP PRACTICE IMPROVEMENT PROJECT

  2013cites this paper
• Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.

  2013cites this paper
• Treatment of Coronary Artery Bypass Graft Failure

  2013cites this paper
• Randomized Trial Bypass Graft Surgery : Analysis From the Post-Myocardial Infarction Free Rx Event and Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery

  2013influential citation
• ACCF/AHA Practice Guideline

  2013cites this paper
• Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event and Economic Evaluation (FREEE) Randomized Trial

  2013influential citation
• Determinants of long-term outcome following bypass surgery

  2012cites this paper
• Association Task Force on Practice Guidelines Summary : A Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive

  2012cites this paper
• Under-Prescribing and Non-Adherence to Medications after Coronary Bypass Surgery in Older Adults

  2012cites this paper
• Treatment of hypertension in patients undergoing coronary artery by-pass grafting.

  2012cites this paper
• Differences in angiotensin convertase enzyme (ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgery.

  2012cites this paper
• 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2012cites this paper
• Secondary Prevention Following Coronary Artery Bypass Surgery: A Pilot Study for Improved Patient Education

  2012cites this paper
• Implantation of the eSVS Mesh

  2012cites this paper
• Foundation/American Heart Association Task Force on Practice Guidelines Executive Summary : A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery:

  2012cites this paper
• Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.

  2012cites this paper
• Analysis of treatment goals in secondary prevention of CAD after CABG

  2012cites this paper
• ACCF/AHA Practice Guideline 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• Postoperative Statin Therapy Attenuates the Intensity of Systemic Inflammation and Increases Fibrinolysis After Coronary Artery Bypass Grafting

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary

  2011cites this paper
• Medications and associated symptoms/problems after coronary artery bypass surgery.

  2011cites this paper
• Secondary Prevention After Coronary Artery Bypass Graft Surgery: Findings of a National Randomized Controlled Trial and Sustained Society-Led Incorporation Into Practice

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cites this paper
• Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cites this paper
• Bypass Conduit Options

  2010cites this paper
• Clopidogrel Provides Significantly Greater Inhibition of Platelet Activity Than Aspirin When Combined With Atorvastatin After Coronary Artery Bypass Grafting: A Prospective Randomized Study

  2010influential citation
• Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.

  2010cites this paper
• Early Antiplatelet Therapy in Coronary Artery Bypass Grafting a Calculated Benefit

  2010cites this paper
• Impact of combination medical therapy on mortality in vascular surgery patients.

  2010cites this paper
• Mortality reduction with beta-blockers in ischemic cardiomyopathy patients undergoing coronary artery bypass grafting.

  2010cites this paper
• Coronary Artery Bypass Graft in a Young Adult, An Emerging Phenomenon: A Case Report.

  2010cites this paper
• With Atorvastatin After Coronary Artery Bypass Grafting : A Prospective Randomized Study Clopidogrel Provides Significantly Greater Inhibition of Platelet Activity Than Aspirin When Combined

  2010influential citation
• Statin treatment equalizes long-term survival between patients with single and bilateral internal thoracic artery grafts.

  2009cites this paper
• Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events

  2009influential citation
• Coronary Artery Bypass Surgery: Science and Practice

  2009cites this paper
• Treatment of locally advanced esophageal cancer with surgery and chemoradiation

  2008cites this paper
• Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry

  2008cites this paper
• PCI or CABG: which patients and at what cost?

  2007cites this paper
• Recommandations de l'Académie nationale de médecine pour la prise en charge des patients après infarctus du myocarde.

  2007cites this paper
• [Secondary prevention after myocardial infarction].

  2007cites this paper
• Midterm Results Of Off-Pump Coronary Artery Bypass Surgery In Indian Patients

  2006cites this paper
• The year in cardiovascular surgery.

  2004cites this paper